As the coronavirus pandemic continues to take a toll on people and businesses worldwide, Logistyx remains committed to serving as a trusted advisor to our customers as they adjust their parcel shipping strategies to sustain the health and safety of the global populations they serve. In awe of what’s being done, we think this great work deserves some recognition.
Investigational Coronavirus Treatment Reaches Patients Faster
Leading biopharmaceutical company, Gilead Sciences, has been contributing towards the global effort to fight the pandemic with its investigational drug which is currently being trialed against the novel coronavirus that causes COVID-19.
What better way to ship a medicine quickly than using Logistyx’s technology? To more promptly move shipments of this investigational medicine past holding at points of entry, Gilead called on Logistyx to add a new medically approved carrier service to its network to fast track the process. After reconfiguring codes within the Logistyx system to print carrier-compliant service labels, Gilead was able to quickly test print and integrate the labels to rapidly increase delivery speed of this medicine from its manufacturing location to medical facilities in need around the globe.
We commend Gilead for shipping swiftly to positively contribute to the fight against COVID-19. While this pandemic is grueling for all businesses, those that successfully reorganize to evolve along with the marketplace can help customers persevere, adapt and ultimately thrive.
To see how your company can efficiently modify shipping strategies to manage the impact of COVID-19 and prepare for its future effects, contact us today.